Skip to main content
TipRanks
Go Ultimate75% OFF

AIM Vaccine Co., Ltd. Class H (6660) Income Statement

2 Followers

AIM Vaccine Co., Ltd. Class H Income Statement

Last quarter (Q2 2026), AIM Vaccine Co., Ltd. Class H's total revenue was ¥345.79M, a decrease of 35.63% from the same quarter last year. In Q2, AIM Vaccine Co., Ltd. Class H's net income was ¥-121.13M. See AIM Vaccine Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 1.15B¥ 1.29B¥ 1.19B¥ 1.26B¥ 1.57B
¥ 760.20M¥ 953.51M¥ -611.21M¥ 1.03B¥ 1.29B
¥ 968.08M¥ 1.16B¥ 2.90B¥ 1.47B¥ 1.94B
Depreciation and Amortization¥ 158.33M¥ 172.03M¥ 174.70M¥ 166.44M¥ 144.29M
¥ -49.54M¥ -57.89M¥ -2.05B¥ -242.03M¥ -451.71M
¥ -207.87M¥ -210.91M¥ -3.51B¥ -384.33M¥ -648.73M
¥ -558.69M¥ -79.80M¥ 1.24B¥ -49.83M¥ 42.03M
¥ -766.56M¥ -290.72M¥ -2.27B¥ -434.17M¥ -606.70M
¥ -675.46M¥ -277.23M¥ -1.30B¥ -319.60M¥ -692.77M
Per Share Metrics
Basic EPS¥ -0.55¥ -0.23¥ -1.07¥ -0.31¥ -0.72
Diluted EPS¥ -0.55¥ -0.23¥ -1.07¥ -0.31¥ -0.72
Weighted Average Shares Outstanding1.22B1.21B1.21B1.03B962.19M
Weighted Average Shares Outstanding (Diluted)1.22B1.21B1.21B1.03B962.19M

Currency in CNY

AIM Vaccine Co., Ltd. Class H Earnings and Revenue History

-1.5B01.5B3B-120 %-60 %0 %60 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin